Andrew D Laurie

Summary

Country: New Zealand

Publications

  1. ncbi Evaluation of high-resolution melting analysis for screening the LDL receptor gene
    Andrew D Laurie
    Molecular Pathology, Canterbury Health Laboratories, Christchurch, New Zealand
    Clin Biochem 42:528-35. 2009
  2. ncbi Detection of factor VIII gene mutations by high-resolution melting analysis
    Andrew D Laurie
    Department of Molecular Pathology, Canterbury Health Laboratories, Christchurch, New Zealand
    Clin Chem 53:2211-4. 2007
  3. ncbi Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches
    A D Laurie
    Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand
    J Thromb Haemost 8:783-9. 2010
  4. ncbi Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa
    Vivienne M Homer
    Canterbury Health Laboratories, 8001 Christchurch, New Zealand
    Atherosclerosis 196:659-66. 2008
  5. ncbi Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand
    Lauretta A Muir
    Centre for Postgraduate Nursing Studies, University of Otago, Christchurch, Christchurch, New Zealand
    N Z Med J 123:97-102. 2010

Collaborators

Detail Information

Publications5

  1. ncbi Evaluation of high-resolution melting analysis for screening the LDL receptor gene
    Andrew D Laurie
    Molecular Pathology, Canterbury Health Laboratories, Christchurch, New Zealand
    Clin Biochem 42:528-35. 2009
    ..High-resolution melting analysis has been validated for screening several genes of clinical significance. We evaluated whether it would be useful for detecting mutations in the LDL receptor gene (LDLR)...
  2. ncbi Detection of factor VIII gene mutations by high-resolution melting analysis
    Andrew D Laurie
    Department of Molecular Pathology, Canterbury Health Laboratories, Christchurch, New Zealand
    Clin Chem 53:2211-4. 2007
    ..Because F8 is a large gene, mutation screening using denaturing HPLC or DNA sequencing is time-consuming and expensive...
  3. ncbi Preimplantation genetic diagnosis for hemophilia A using indirect linkage analysis and direct genotyping approaches
    A D Laurie
    Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand
    J Thromb Haemost 8:783-9. 2010
    ..Although many clinics offer PGD for HA by gender selection, an approach that detects the presence of the underlying F8 mutation has several advantages...
  4. ncbi Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa
    Vivienne M Homer
    Canterbury Health Laboratories, 8001 Christchurch, New Zealand
    Atherosclerosis 196:659-66. 2008
    ..Our study therefore indicates that PCSK9 mediated inhibition of the LDLR does not require PCSK9 autocatalytic cleavage or secretion, suggesting that PCSK9 may also function intracellularly...
  5. ncbi Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand
    Lauretta A Muir
    Centre for Postgraduate Nursing Studies, University of Otago, Christchurch, Christchurch, New Zealand
    N Z Med J 123:97-102. 2010
    ..To identify the diagnostic and treatment rates for familial hypercholesterolaemia (FH) in New Zealand...